SEC Comment Letter for Theriva Biologics, Inc. (TOVX) (CIK 0000894158) (TOVX) — Oct 22, 2008

Theriva Biologics, Inc. (TOVX) (CIK 0000894158)
Date: Oct. 22, 2008 · CIK: 0000894158 · Accession: 0000000000-08-052859

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-12584

Date

October 8, 2008

Author

Joel Parker

Form

UPLOAD

Company

Theriva Biologics, Inc. (TOVX) (CIK 0000894158)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 October 8, 2008 Steve H. Kanzer Chairman and Chief Executive Officer Pipex Pharmaceuticals, Inc. 3930 Varsity Drive Ann Arbor, MI 48108 Re: Pipex Pharmaceuticals, Inc. Form 10-KSB for the Year Ended December 31, 2007 File No. 001-12584

Dear Mr. Kanzer:

We have completed our review of your Form 10-KSB and have no further comments at this time. S i n c e r e l y ,

J o e l P a r k e r A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 6010                                                                                                   October 8, 2008  Steve H. Kanzer Chairman and Chief Executive Officer  Pipex Pharmaceuticals, Inc. 3930 Varsity Drive Ann Arbor, MI 48108
Re: Pipex Pharmaceuticals, Inc.
 Form 10-KSB for the Year Ended December 31, 2007
 File No. 001-12584

Dear Mr. Kanzer:

We have completed our review of your Form 10-KSB and have no further
comments at this time.
          S i n c e r e l y ,

         J o e l  P a r k e r          A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io